FDA Green Lights Bizengri Drug To Treat Rare, Aggressive Bile Duct Cancer MedNews
MONDAY, May 11, 2026 The U.S. Food and Drug Administration (FDA) has approved Bizengri to treat an ultra-rare, aggressive cancer that forms in the bile ducts. B
